Company / Working Capital per Share
Stoke Therapeutics, Inc. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.59
FY2025
5-year range
$4.20 / $5.77
FY2021-FY2025
Trend
+9.3%
vs FY2024
Sector context
#115 of 210
Health Care
What the data says
At $4.59, Stoke Therapeutics, Inc.'s working capital per share ranks #115 of 210 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 6 years of decline, reaching $4.59.
Based on SEC 10-K filings.
4.59 in FY2025 with a 5-year CAGR of -11.5%.
Remained stable around $4.59 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -7.3%
- 5-Year CAGR
- -11.5%
- 10-Year CAGR
- -
Sector benchmark
#115 of 210 in Health CareTop 55% of 210This company $4.59 Sector average $146.86
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 9.3% year-over-year.
- Ranks #115 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2018.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.59 | +9.3% |
| FY2024 | $4.20 | -10.3% |
| FY2023 | $4.68 | -18.8% |
| FY2022 | $5.76 | -0.2% |
| FY2021 | $5.77 | -31.6% |
| FY2020 | $8.44 | -31.7% |
| FY2019 | $12.35 | -91.6% |
| FY2018 | $146.16 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026